BackUltragenyx Pharmaceutical Overview
Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical PEG Ratio

Ultragenyx Pharmaceutical (RARE) has a PEG ratio of 22.72, above the Healthcare sector average of 1.26.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

22.72

PEG Ratio

22.72

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Ultragenyx Pharmaceutical (RARE) FAQ

As of the most recent data, RARE shows a PEG ratio of 22.72. That is above the Healthcare sector average of 1.26. Scroll down for historical charts and peer comparison views.

The Healthcare sector average PEG ratio is about 1.26. Ultragenyx Pharmaceutical is at 22.72, which is higher that average. That is roughly 1707.0% above the sector mean. Use the comparison chart on this page to see how RARE stacks up against individual peers as well.

Investors watch RARE's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Ultragenyx Pharmaceutical's latest reading is 22.72. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has Ultragenyx Pharmaceutical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 22.72) with ownership activity and broader fundamentals.

The Healthcare average PEG ratio is about 1.26, while RARE is at 22.72. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.